SENOMYX, INC. FIRST QUARTER 2017 EARNINGS CONFERENCE CALL SCHEDULED FOR APRIL 27, 2017
SAN DIEGO, April 18, 2017 /PRNewswire/ -- Senomyx, Inc. (NASDAQ:SNMX) will release its financial results for the first quarter ended March 31, 2017 on Thursday, April 27, 2017, after the close of the U.S. financial markets. The Company will also host a conference call with a live Internet broadcast that will provide a corporate update and a review of its first quarter results on the same day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
To participate in the live conference call, U.S. residents should dial 844-825-0514, and international callers should dial 315-625-6892 at least 10 minutes prior to the call start time. The conference ID for this call is 97603082.
To access the live Internet broadcast or a subsequent archived recording, please log onto the Investor Relations section of Senomyx's website at http://investor.senomyx.com. The archived webcast will be available for 30 days following the presentation. Please connect to Senomyx's website prior to the start of the webcast to ensure adequate time to download any software that may be necessary.
About Senomyx, Inc. (www.senomyx.com)
Senomyx discovers and develops novel natural high intensity sweeteners and flavor ingredients that allow food and beverage companies to create better-for-you products. Under its direct sales program, Senomyx sells its Complimyx® brand flavor ingredients, Sweetmyx®, Savorymyx®, and Bittermyx®, to flavor companies for use in a wide variety of foods and beverages. In addition, Senomyx has partnerships with leading global food, beverage, and ingredient supply companies, which are currently marketing products that contain Senomyx's flavor ingredients. For more information, please visit www.senomyx.com.
Senior Vice President &
Chief Financial Officer
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/senomyx-inc-first-quarter-2017-earnings-conference-call-scheduled-for-april-27-2017-300440501.html
SOURCE Senomyx, Inc.